TC BioPharm Regains Nasdaq Compliance

TC Biopharm (Holdings) Plc Sponsored ADR (TCBP) has released an update.

TC BioPharm (Holdings) Plc announced it has regained compliance with Nasdaq’s minimum equity and bid price requirements, avoiding the usual Mandatory Panel Monitor due to early compliance. The company is now subject to a one-year Discretionary Panel Monitor to ensure sustained adherence to listing standards. Failure to maintain compliance could lead to a swift delisting without the possibility of presenting a compliance plan.

For further insights into TCBP stock, check out TipRanks’ Stock Analysis page.